Tempus AI(TEM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TEM Tempus AI

Trading 02-05 14:38:17 EST

51.98

-1.57

-2.93%

High55.00	Low51.20	Vol6.49M
Open54.51	D1 Closing53.55	Amplitude7.10%
Mkt Cap9.25B	Tradable Cap5.29B	Total Shares177.91M
T/O344.93M	T/O Rate6.38%	Tradable Shares101.68M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TEM","market":"US","secType":"STK","nameCN":"Tempus AI","latestPrice":51.98,"timestamp":1770320294942,"preClose":53.55,"halted":0,"volume":6490408,"delay":0,"changeRate":-0.029318394024276384,"floatShares":101682878,"shares":177907259,"eps":-1.189108,"marketStatus":"Trading","change":-1.57,"latestTime":"02-05 14:38:17 EST","open":54.51,"high":55,"low":51.2,"amount":344934070.184048,"amplitude":0.070962,"askPrice":52.01,"askSize":200,"bidPrice":51.97,"bidSize":22,"shortable":0,"etf":0,"ttmEps":-1.189108,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770325200000},"marketStatusCode":2,"adr":0,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":53.55,"preHourTrading":{"tag":"盘前","latestPrice":54.71,"preClose":53.55,"latestTime":"09:29 EST","volume":142827,"amount":7652283.59883,"timestamp":1770301799567,"change":1.16,"changeRate":0.021662,"amplitude":0.072082},"postHourTrading":{"tag":"盘后","latestPrice":53.75,"preClose":53.55,"latestTime":"19:59 EST","volume":158231,"amount":8477833.4531,"timestamp":1770253170497,"change":0.2,"changeRate":0.003735,"amplitude":0.014971},"volumeRatio":1.286571,"optionData":{"bulkOrders":[{"symbol":"TEM","call":false,"expireDate":1781755200000,"strike":"45.0","timestamp":1770302824071,"price":4.85,"volume":2000,"amount":970000,"type":"+"}]},"impliedVol":0.8178,"impliedVolPercentile":0.4143},"requestUrl":"/m/hq/s/TEM","defaultTab":"news","newsList":[{"id":"2608366509","title":"Tempus AI-Tochter Ambry Genetics unterstützt bahnbrechende Forschung zu Krebsgenen","url":"https://stock-news.laohu8.com/highlight/detail?id=2608366509","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608366509?lang=en_us&edition=fundamental","pubTime":"2026-02-04 20:01","pubTimestamp":1770206474,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL8Rtft7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","LU1861559042.SGD","BK4611","TEM","BK4121","BK4613"],"gpt_icon":1},{"id":"2608861213","title":"What's Going On With Tempus AI Stock Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2608861213","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608861213?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:03","pubTimestamp":1770037380,"startTime":"0","endTime":"0","summary":"Ambry Genetics, a subsidiary of Tempus AI, announced completion of 1 million DNA/RNA tests for hereditary cancer and rare disease.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/02/Tempus-Logo-Displayed-On-Smartphone.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/02/Tempus-Logo-Displayed-On-Smartphone.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/02/50296224/whats-going-on-with-tempus-ai-stock-monday-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/02/50296224/whats-going-on-with-tempus-ai-stock-monday-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IE0009354923.USD","BK4613","BK4139","BK4588","BK4109","BK4505","BK4543","BK4611","BK4585","BK4528","BK4217","LU1861559042.SGD","BK4551","LU1861558580.USD","BK4121","BK4023","BK4587","TEM"],"gpt_icon":1},{"id":"2608865069","title":"Ambry Genetics Hits One Million RNA-Enhanced Genetic Tests Under Tempus AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2608865069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608865069?lang=en_us&edition=fundamental","pubTime":"2026-02-02 20:00","pubTimestamp":1770033651,"startTime":"0","endTime":"0","summary":"Ambry Genetics, a leader in clinical genomic testing, is a wholly owned subsidiary of Tempus AI, Inc. . Ambry Genetics has pioneered paired DNA/RNA testing for hereditary cancer and recently completed its one-millionth DNA/RNA test. The company first implemented RNA testing in 2016 and launched its commercial +RNAinsight test in 2019. In 2024, Ambry Genetics added RNA testing to its ExomeReveal offering to improve diagnostic yield in rare disease cases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire  on February 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL8n7tPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","TEM","BK4121","BK4611","BK4613","LU1861559042.SGD"],"gpt_icon":0},{"id":"2607202194","title":"Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2607202194","media":"Reuters","labels":["insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607202194?lang=en_us&edition=fundamental","pubTime":"2026-01-31 05:16","pubTimestamp":1769807762,"startTime":"0","endTime":"0","summary":"Eric P. Lefkofsky, CEO and Chairman of Tempus AI Inc., reported a disposal of Class A common shares of Tempus AI Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDLVCjLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares","news_tag":"insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM","LU1861559042.SGD","BK4611","BK4613","BK4121","LU1861558580.USD"],"gpt_icon":1},{"id":"2607040225","title":"Assessing Tempus AI (TEM) Valuation After New Immune Profile Score Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2607040225","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607040225?lang=en_us&edition=fundamental","pubTime":"2026-01-30 19:37","pubTimestamp":1769773030,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has drawn fresh attention after releasing clinical validation data on its Immune Profile Score test, which the company reports more accurately predicts which cancer patients benefit from immune checkpoint inhibitors than conventional biomarkers.\nSee our latest analysis for Tempus AI.\nThose IPS results arrive after a busy month for Tempus AI, with the launch of Paige Predict in digital pathology and fresh attention from high profile investors such as ARK and Nancy Pelosi. Even...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/assessing-tempus-ai-tem-valuation-after-new-immune-profile-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/assessing-tempus-ai-tem-valuation-after-new-immune-profile-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4543","BK7095","BK4585","LU1861558580.USD","BK4611","BK4023","BK4528","BK4587","BK4551","BK4613","LU1861559042.SGD","TEM","BK4121","BK4588"],"gpt_icon":1},{"id":"1195673734","title":"Form 144 | Tempus AI's Officer Eric Lefkofsky proposes to sell 166,250 Shares, with a total value of approximately $11.1 Million.","url":"https://stock-news.laohu8.com/highlight/detail?id=1195673734","media":"Filings Track","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195673734?lang=en_us&edition=fundamental","pubTime":"2026-01-29 05:25","pubTimestamp":1769635516,"startTime":"0","endTime":"0","summary":"Tempus AI's Officer Eric Lefkofsky proposes to sell 166,250 shares of common stock on January 28, 2026, with a total market value of approximately $11.1 million. Eric Lefkofsky is also a director and a 10% stockholder.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Form 144 | Tempus AI's Officer Eric Lefkofsky proposes to sell 166,250 Shares, with a total value of approximately $11.1 Million.","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEM"],"gpt_icon":0},{"id":"2606780253","title":"Tempus Says Study Shows AI-Driven Test More Accurately Predicts Immunotherapy Benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780253","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606780253?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:24","pubTimestamp":1769523886,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) said Tuesday that results of a new study show that its Immune Profile Score algorithmic test predicts outcomes for patients receiving immune checkpoint inhibitors more accurately than ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4611","LU1861559042.SGD","TEM","BK4613","BK7095","LU1861558580.USD","BK4121"],"gpt_icon":0},{"id":"2606271269","title":"Cathie Wood Sells Biotech Stocks, Bets Big on Tempus AI and WeRide","url":"https://stock-news.laohu8.com/highlight/detail?id=2606271269","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606271269?lang=en_us&edition=fundamental","pubTime":"2026-01-27 11:30","pubTimestamp":1769484613,"startTime":"0","endTime":"0","summary":"Cathie Wood’s ARK Invest ETFs released their daily trade disclosures for Monday, January 26, 2026, highlighting fresh moves across biotech and arti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/cathie-wood-sells-biotech-stocks-bets-big-on-tempus-ai-and-weride?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/cathie-wood-sells-biotech-stocks-bets-big-on-tempus-ai-and-weride?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEM","LU1861559042.SGD","ARKK","LU1861558580.USD","BK4588","BK4611","BK4613","BK4585","BK4544","BK4121"],"gpt_icon":0},{"id":"2606560275","title":"Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=2606560275","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606560275?lang=en_us&edition=fundamental","pubTime":"2026-01-27 09:56","pubTimestamp":1769478960,"startTime":"0","endTime":"0","summary":"On Monday, Jan. 26, 2026, Cathie Wood's Ark Invest deployed approximately $1.4 million across three AI companies—Tempus AI, Kodiak AI, and WeRide","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/26/Ark-Invest-Cathie-Wood.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/26/Ark-Invest-Cathie-Wood.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/01/50146208/cathie-wood-bets-big-on-ai-trifecta-ark-deploys-1-4-million-across-medical-autonomous-driving-sectors","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/etfs/broad-u-s-equity-etfs/26/01/50146208/cathie-wood-bets-big-on-ai-trifecta-ark-deploys-1-4-million-across-medical-autonomous-driving-sectors","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4121","BK4588","BK4609","WRD","BK4551","BK4023","KDK","00800","TEM","BK4528","LU1861558580.USD","LU1861559042.SGD","BK4544","BK4587","BK4611","BK4613","BK4585","BK4543","BK4124"],"gpt_icon":1},{"id":"1127780348","title":"Software Stocks Jump With Cloudflare up 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1127780348","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127780348?lang=en_us&edition=fundamental","pubTime":"2026-01-26 23:27","pubTimestamp":1769441256,"startTime":"0","endTime":"0","summary":"Software stocks jumped in morning trading. $Cloudflare(NET)$ rose 10%; $Tempus AI(TEM)$ rose 7%; $Zoom(ZM)$ rose 6%; $GitLab(GTLB)$, $AppLovin(APP)$, and $Unity(U)$ rose 4%; $Datadog(DDOG)$ rose 3%; $ServiceNow(NOW)$ rose 3%.   ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"08fdd2339d63f2b4946d465b31332040","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GTLB","NOW","TEM","DDOG","NET","APP","ZM","U"],"gpt_icon":0},{"id":"2605210772","title":"Tempus AI Launches Paige Predict to Advance Digital Pathology","url":"https://stock-news.laohu8.com/highlight/detail?id=2605210772","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605210772?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:30","pubTimestamp":1769002249,"startTime":"0","endTime":"0","summary":"Tempus AI Inc. has announced the launch of Paige Predict, a new suite of digital pathology applications designed to analyze H&E whole slide images and help inform testing decisions in cancer care. The AI-powered platform predicts the presence or absence of clinically relevant biomarkers from a single slide, aiding physicians even when tissue samples are limited. Built using Paige's foundation model and a combined dataset from both Tempus and Paige, Paige Predict leverages data from over 200,000 patients and covers 123 biomarkers across 16 cancer types. This launch follows Tempus's acquisition of Paige and represents an expansion of the company’s offerings in digital pathology and precision medicine.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or leg","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL6wpD5T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4611","LU1861558580.USD","BK4613","TEM","LU1861559042.SGD"],"gpt_icon":1},{"id":"1148891294","title":"24H | AI Application Software Stocks Fall. Rezolve AI Plunges over 11%; AppLovin Sinks over 5%; SOUN, Unity Down Around 4%; Palantir Down over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148891294","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148891294?lang=en_us&edition=fundamental","pubTime":"2026-01-20 16:43","pubTimestamp":1768898612,"startTime":"0","endTime":"0","summary":"AI application software stocks fell in overnight trading. Rezolve AI down over 11%; AppLovin down over 5%; Tempus AI, SOUN, BBAI, Unity down around 4%; Palantir down over 3%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d0dbcd0a7c79f70d503363982288c4ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DDOG","LMND","APP","RZLV","RBRK","TEM","U","RDDT","TEAM","FIG","BBAI","GTLB","BRZE","NOW","CRNC","ADBE","ADP","HUBS","DUOL","AI","SOUN","TTD","CRM","UPST","PLTR"],"gpt_icon":0},{"id":"2603508504","title":"Record 2025 Revenue and New Cancer Data Deals Might Change The Case For Investing In Tempus AI (TEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603508504","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603508504?lang=en_us&edition=fundamental","pubTime":"2026-01-13 11:22","pubTimestamp":1768274578,"startTime":"0","endTime":"0","summary":"In the past few days, Tempus AI reported preliminary 2025 results showing roughly US$1.27 billion in revenue with very large year-over-year growth, a record total contract value above US$1.10 billion, and more than 70 data agreements alongside new oncology collaborations with NYU Langone Health and Northwestern Medicine.\nTogether, these updates point to a company deepening its role at the intersection of genomic testing, longitudinal cancer data, and AI-powered decision support for both...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/record-2025-revenue-and-new-cancer-data-deals-might-change-t","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/record-2025-revenue-and-new-cancer-data-deals-might-change-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4611","BK4121","BK4588","BK4585","BK4543","BK7095","LU1861559042.SGD","TEM","BK4587","BK4613","BK4551","BK4528","BK4023","LU1861558580.USD"],"gpt_icon":1},{"id":"1196196817","title":"Tempus Posts Strong Preliminary 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1196196817","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196196817?lang=en_us&edition=fundamental","pubTime":"2026-01-13 04:41","pubTimestamp":1768250471,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) climbed 4.3% in late trading on Monday, following the company's release of a robust preliminary performance report for 2025.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"70523e6ad4689589f23b821eb9a234ee","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B894F039.SGD","LU0353189680.USD","BK4121","APP","LU1861559042.SGD","LU2360107168.USD","LU1861558580.USD","LU2087625088.SGD","IE00BZ9MQY76.HKD","BK4611","BK4585","BK4588","LU1852331112.SGD","LU1861220033.SGD","LU2290526834.HKD","TEM","BK4613","BK4023","LU0353189763.USD","LU1861215975.USD","LU0056508442.USD","BK4608","LU2360106780.USD","LU2250418816.HKD","IE00B19Z9Z06.USD","BK4539","LU2063271972.USD","LU0097036916.USD","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2603737544","title":"Nancy Pelosi's Latest Trades Are Heating Up — Tempus AI's 100% Stock Surge Is Leading The Charge","url":"https://stock-news.laohu8.com/highlight/detail?id=2603737544","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603737544?lang=en_us&edition=fundamental","pubTime":"2026-01-12 23:58","pubTimestamp":1768233480,"startTime":"0","endTime":"0","summary":"Tempus AI stock is soaring Monday. Here's why Nancy Pelosi's portfolio is smiling.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/12/Armenia--Yerevan-18-September-2022-U-s--.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/12/Armenia--Yerevan-18-September-2022-U-s--.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/26/01/49848929/nancy-pelosis-latest-trades-are-heating-up-tempus-ais-100-stock-surge-is-leading-the-charge","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/01/49848929/nancy-pelosis-latest-trades-are-heating-up-tempus-ais-100-stock-surge-is-leading-the-charge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1861558580.USD","TEM","BK4121","BK4528","AI","BK4611","BK4587","BK4551","BK4588","BK4613","LU1861559042.SGD","BK4023","BK4585","BK4543"],"gpt_icon":0},{"id":"2602354661","title":"Tempus AI Shares Hit Over One-Month High, Last up 12% After Prelim Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2602354661","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602354661?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:33","pubTimestamp":1768228431,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","BK4611","LU1861559042.SGD","LU1861558580.USD","BK4121","TEM"],"gpt_icon":0},{"id":"2602545934","title":"Tempus AI Shares Rise After Preliminary 4Q Results Beat Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2602545934","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602545934?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:15","pubTimestamp":1768227300,"startTime":"0","endTime":"0","summary":"Shares of Tempus AI rose after the company reported preliminary fourth-quarter revenue above Wall Street's expectations.The stock rose 12% to $74.50 in premarket trading after closing Friday up 12% this year.On Sunday, the company reported preliminary fourth-quarter revenue of $367 million, above Wall Street's forecast of $360.6 million, according to FactSet.On Monday, the company said it was selected by Northwestern Medicine to expand genomic testing for cancer patients. It also said it has formed a multi-year collaboration with NYU Langone Health focused on improving cancer care through advanced molecular profiling.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861559042.SGD","LU1861558580.USD","BK4121","TEM","BK4611","BK4613"],"gpt_icon":1},{"id":"2602543079","title":"Sector Update: Health Care Stocks Lower Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543079","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602543079?lang=en_us&edition=fundamental","pubTime":"2026-01-12 22:06","pubTimestamp":1768226782,"startTime":"0","endTime":"0","summary":"Health care stocks were lower premarket Monday, with the State Street Health Care Select Sector SPDR ETF  and the iShares Biotechnology ETF  each falling 0.1%.Tempus AI  stock was up more than 12% premarket after the company reported higher preliminary Q4 revenue.Abivax  shares were up more than 22% pre-bell after French media outlet La Lettre reported that Eli Lilly  was preparing a 15-billion-euro  takeover offer for the biotech startup.Natera  stock gained more than 1% before the bell after the company reported higher preliminary Q4 revenue late Sunday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1814569148.SGD","LU1868837136.USD","LU1974910355.USD","LU2750360997.AUD","LU1551013342.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","LU0354030438.USD","LU2471134796.USD","LU0061475181.USD","LU1720051017.SGD","LU0353189680.USD","LU1267930730.SGD","IE00BK4W5M84.HKD","LU0417517546.SGD","LU2491049909.HKD","SG9999015986.USD","BK4588","IE00BK4W5L77.USD","LU1069344957.HKD","LU0114720955.EUR","LU2063271972.USD","LU2168564495.EUR","SG9999013999.USD","IE00BJT1NW94.SGD","LU2471134952.CNY","IE00BJLML261.HKD","LU0385154629.USD","LU0683600562.USD","LU2471134879.HKD","LU0289739699.SGD","LU2361044865.SGD","LU0345770308.USD","LU0943347566.SGD","LU1989771016.USD","SGXZ99366536.SGD","LU0466842654.USD","LU1548497426.USD","SG9999015978.USD","LU1868836757.USD","BK7095","SGXZ51526630.SGD","LU2236285917.USD","IE00BN29S564.USD","LU2552382215.SGD","LU1035775433.USD","LU0320765992.SGD","LU2552382132.HKD","LU1712237335.SGD","LU0471298777.SGD","IE00B1XK9C88.USD","LU0672654240.SGD","LU0266013472.USD","LU2065171402.SGD","LU2065171311.SGD","LU2108987350.USD","LU2112291526.USD","BK4139","XBI","LU0256863811.USD","SG9999015945.SGD","LU2237443382.USD","LU2089984988.USD","LU2746668461.USD","LU0198837287.USD","LU0012050646.USD","LU0963586101.USD","LU1720051108.HKD","SG9999001176.SGD","LU0094547139.USD","XLV","LU0106261612.USD","LU1061106388.HKD","LABU","LU0882574055.USD","LU1623119135.USD","LU0053671581.USD","LU1988902786.USD","LU2324357040.USD","SG9999015952.SGD","LU2746668974.SGD","SGXZ81514606.USD","LU2168564065.EUR","LU2237443549.SGD","LU1127390331.HKD","LU2468319806.SGD","IE00BKPKM429.USD","IE00B1BXHZ80.USD","IE0002141913.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","SGXZ31699556.SGD","IE00B775H168.HKD","LU0823434583.USD","LU1861558580.USD","LU2065731478.USD","BK4585","LU0079474960.USD","IBB","IE00B7KXQ091.USD","LU2602419157.SGD","LU0786609619.USD","LU1064131342.USD","LU0238689110.USD","BK4613","IE0009355771.USD","LU2065169927.USD","BK4007","LU0708995401.HKD","LU1366192091.USD","LU1917777945.USD","IE0005OL40V9.USD","LU2456880835.USD","LU2471134523.USD","IE00BJJMRY28.SGD","LU2462157665.USD","LU0096364046.USD","LU0203202063.USD","IE00BFSS8Q28.SGD","SG9999001176.USD","LU2168564222.USD","LU2168564149.EUR","TEM","ABVX","LU2237443895.HKD","SG9999014914.USD","LU2211815571.USD","LU0640476718.USD","SG9999018865.SGD","LU0820561909.HKD","LU2265009873.SGD","SG9999017495.SGD","LU1868836591.USD","IE00BKDWB100.SGD","LU2237443622.USD","LU2264538146.SGD","LU1804176565.USD","LU0823434740.USD","LU2361044949.HKD","BK4533","LU0432979614.USD","LU1551013425.SGD","LU0345770993.USD","LU2360106947.USD","LU0354030511.USD","LU0689472784.USD","LU2357305700.SGD","LU0203201768.USD","BK4611","LU0823416689.USD","LU0787776722.HKD","LU2237438978.USD","LU0882574139.USD","GB00BDT5M118.USD","LU0097036916.USD","LU0109394709.USD","BK4581","LU2491050071.SGD","LU0456855351.SGD","SG9999014906.USD","LU2461242641.AUD","LU0234572021.USD","LU2750360641.GBP","LU2552382058.USD","LU0316494557.USD","LU0225283273.USD","LU1280957306.USD","BK4534","LU1868836914.USD","BK4599","IE00B4R5TH58.HKD","LU2168563687.JPY","SG9999014880.SGD","BK4516","LU2065170008.USD","IE00B4JS1V06.HKD","LU0106261372.USD","LU0353189763.USD","LU0122379950.USD","LU1323610961.USD","IE00B2B36J28.USD","LU1861559042.SGD","LU1232071149.USD","LU0320765059.SGD","IE00BJJMRX11.SGD","LU1093756168.USD","LU2417539215.USD","LU0109391861.USD","IE00BFSS7M15.SGD","LU0058720904.USD","LU2023250504.SGD","LU0256863902.USD","LU1868837300.USD","LU2106854487.HKD","LU1291159041.SGD","LU0889565916.HKD","LU1093756325.SGD","LU2237443465.HKD","LU2237443978.SGD","SGXZ57979304.SGD","LU2491050154.USD","LU0820561818.USD","SG9999018857.SGD","LU2087625088.SGD","LLY","LU0006306889.USD","LU0471298694.HKD","LU2361045086.USD","LU1983299246.USD","BK4121","IE0004445239.USD","IE00BWXC8680.SGD","IE0004445015.USD","LU0323591593.USD","SG9999014898.SGD"],"gpt_icon":0},{"id":"2602202512","title":"S&P 500 Futures Fall In Premarket Trading; Tempus AI, Klarna Group Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2602202512","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602202512?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:31","pubTimestamp":1768221060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, Tempus AI Inc.  was up 12.4% in pre-market trading, and Klarna Group PLC  was up 6.6%.Krystal Biotech Inc. , Hecla Mining Co. , and First Majestic Silver Corp.  were all posting gains of at least 5%. In early trading, Synchrony Financial  and Capital One Financial Corp.  had posted declines, falling 9.3% and 8.7%, respectively.Meanwhile S&P 500 futures were down 0.56%, with futures for the Dow Jones Industrial Average falling 0.71%. The Cboe Volatility Index futures were down 2.18%.In commodities news, Brent crude oil futures were down 0.63%, while gold futures were up 1.99%. Bitcoin was up 0.18% to $90,740.In the previous regular trading session, the S&P 500 and the Dow were up 0.65% and 0.48%, respectively. In Asia overnight, China's Shanghai Composite Index was up 1.09%.In afternoon trading, stocks in Europe are mixed, with the STOXX Euro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4121","KRYS","LU1201861249.SGD","LU0477156953.USD","AG","IVV","LU1861559042.SGD","SH","COF","LU1861558580.USD","LU1668664300.SGD","LU0648000940.SGD","LU1201861165.SGD","BK4611","KLAR","UPRO","OEF","BK4570","BK4585","BK4588","IE000M9KFDE8.USD","LU0477156797.USD","TEM","LU1861217088.USD","BK4166","IE00BFXG1179.USD","MESmain","LU0345780521.USD","LU0787776722.HKD","LU0210528500.USD","BK4227","BK4561","LU0980610538.SGD","LU0130103400.USD","LU1861220207.SGD","LU2487616109.SGD","SDS","SPXU","LU0648001328.SGD","BK4613","LU1323610961.USD","LU2360107671.USD","IE0002270589.USD","LU2108987350.USD","BK4516","BK4581","LU0130518102.USD","LU0053666078.USD","IE00B19Z3B42.SGD","LU0211331839.USD","SSO","IE00B19Z3581.USD","LU1791807156.HKD","ESmain","LU0683600562.USD","BK4534","SYF","OEX","LU0130102774.USD","LU0106831901.USD","BK4504","BK4139","BK4210","BK4550","LU0345780281.USD","HL","LU1074936037.SGD","LU0130517989.USD"],"gpt_icon":1},{"id":"2602251400","title":"Tempus AI Inc. Unveils AI-Driven Platform Advancing Precision Medicine and Data-Powered Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2602251400","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602251400?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:11","pubTimestamp":1768219914,"startTime":"0","endTime":"0","summary":"Tempus AI Inc. delivered a presentation highlighting its advancements in AI-enabled diagnostics and precision medicine. The company outlined the scale of its platform, which is connected to over 5,000 healthcare providers across the United States, including more than 65% of U.S. academic medical centers and over 55% of oncologists. Tempus has accumulated over 45 million patient records and more than 400 petabytes of multimodal healthcare data, enabling the development and delivery of AI-driven insights for physicians, patients, and researchers. The presentation detailed the integration of genomics, clinical, and imaging data to support applications in drug discovery, therapy selection, and clinical trial matching. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL39wJHM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4611","LU1861558580.USD","BK4613","TEM","LU1861559042.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tempus.com","stockEarnings":[{"period":"1week","weight":-0.1707},{"period":"1month","weight":-0.1723},{"period":"3month","weight":-0.2572},{"period":"6month","weight":-0.1203},{"period":"1year","weight":-0.1342},{"period":"ytd","weight":-0.0931}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0022},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.0769},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.0063}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.","exchange":"NASDAQ","name":"Tempus AI","nameEN":"Tempus AI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tempus AI(TEM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tempus AI(TEM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tempus AI,TEM,Tempus AI股票,Tempus AI股票老虎,Tempus AI股票老虎国际,Tempus AI行情,Tempus AI股票行情,Tempus AI股价,Tempus AI股市,Tempus AI股票价格,Tempus AI股票交易,Tempus AI股票购买,Tempus AI股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tempus AI(TEM),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tempus AI(TEM) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}